FDA aprueba la primera molécula para el tratamiento de la Enfermedad de Alexander

FDA Approves First Drug to Treat Alexander Disease New therapy is the first to directly target the underlying cause of this rare neurological disease https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-alexander-disease